Nephrogene systemische Fibrose oder Niereninsuffizienz - Wie hoch ist das Risiko?

Literatur

• 01 Bridges M D, St Amant B S, McNeil R B, Cernigliaro J G, Dwyer J P, Fitzpatrick P M. High-dose gadodiamide for catheter angiography and CT in patients with varying degrees of renal insufficiency: Prevalence of subsequent nephrogenic systemic fibrosis and decline in renal function.  AJR Am J Roentgenol. 2009;  192 1538-1543
• 02 Broomme D R. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.  Eur J Radiol. 2008;  66 230-234
• 03 Persson P B, Hansell P , Liss P . Pathophysiology of Contrast Medium Induced Nephropathy.  Kidney Int. 2005;  68 14-22